EN PL
CASE REPORT
Selected problems of biologic therapy in rheumatoid arthritis patients – pregnancy during therapy. Case reports
 
More details
Hide details
 
Online publication date: 2013-03-05
 
 
Reumatologia 2013;51(1):93-95
 
KEYWORDS
ABSTRACT
Preparation for being pregnant and pregnancy management in rheumatoid arthritis (RA) constitute an important clinical problem. An unfavorable influence on pregnancy may be caused by inflammation per se and organ involvement during RA, but also by applied therapy. Few observations exist concerning the course of pregnancy in RA patients treated with biologics. In this study we present two cases of RA patients, who became pregnant during biologic therapy.
REFERENCES (4)
1.
Partlett R, Roussou E. The treatment of rheumatoid arthritis during pregnancy. Rheumatol Int 2011; 31: 445-449.
 
2.
Hazes JM, Coulie PG, Geenen V, et al. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology (Oxford) 2011; 50: 1955-1968.
 
3.
Verstappen SM, King Y, Watson KD, et al. Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2011; 70: 823-826.
 
4.
Andreoli L, Bazzani C, Taraborelli M, et al. Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. Autoimmun Rev 2010; 10: 51-54.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top